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Abstract
Emotion processing deficits are prominent in schizophrenia and exist prior to the onset of overt
psychosis. However, developmental trajectories of neural circuitry subserving emotion regulation
and the role that they may play in illness onset have not yet been examined in patients at risk for
psychosis. The present study employed a cross-sectional analysis to examine age-related
functional activation in amygdala and prefrontal cortex, as well as functional connectivity between
these regions, in adolescents at clinical high risk (CHR) for psychosis relative to typically
developing adolescents. Participants (n=34) performed an emotion processing fMRI task,
including emotion labeling, emotion matching, and non-emotional control conditions. Regression
analyses were used to predict activation in the amygdala and ventrolateral prefrontal cortex
(vlPFC) based on age, group, sex, and the interaction of age by group. CHR adolescents exhibited
altered age-related variation in amygdala and vlPFC activation, relative to controls. Controls
displayed decreased amygdala and increased vlPFC activation with age, while patients exhibited
the opposite pattern (increased amygdala and decreased vlPFC activation), suggesting a failure of
prefrontal cortex to regulate amygdala reactivity. Moreover, a psychophysiological interaction
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analysis revealed decreased amygdala-prefrontal functional connectivity among CHR adolescents,
consistent with disrupted brain connectivity as a vulnerability factor in schizophrenia. These
results suggest that the at-risk syndrome is marked by abnormal development and functional
connectivity of neural systems subserving emotion regulation. Longitudinal data are needed to
confirm aberrant developmental trajectories intra-individually and to examine whether these
abnormalities are predictive of conversion to psychosis, and of later deficits in socioemotional
functioning.
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1. Introduction
Patients with schizophrenia show impaired performance on tasks engaging a variety of
emotion-related processes (e.g., perception, expression, regulation) (Fakra et al., 2008;
Kohler et al., 2010; Kring & Moran, 2008). Deficits in emotion processing are generally
refractory to interventions (Harvey et al., 2006; Penn et al., 2009; Sergi et al., 2007) and are
strongly related to social and occupational impairments, both contemporaneously and
prospectively (Hooker & Park, 2002; Kee et al., 2003; Mueser et al., 1996). Thus,
understanding the timing of onset and neural underpinnings of emotion-related deficits could
lead to more effective approaches to treatment and prevention of functional disabilities in
schizophrenia.
Schizophrenia patients show decreased functional connectivity of the amygdala and
prefrontal cortex during emotion processing (Fakra et al., 2008). Whether reduced functional
connectivity is a cause or consequence of schizophrenia (or its treatment) is not yet clear.
However, because individuals at clinical high risk (CHR) for psychosis exhibit emotion-
related behavioral deficits (Phillips & Seidman, 2008; Addington et al., 2008; Kim et al.,
2010; van Rijn et al., 2011) and healthy individuals with high psychosis-proneness display
decreased cognitive control of emotion (Modinos, Ormel, & Aleman, 2010), abnormal
functional connectivity in networks subserving emotion processing might predate (and
potentially contribute to) psychosis onset.
Disrupted neurodevelopmental processes resulting in reduced structural and functional brain
connectivity are hypothesized to play a key role in the onset of schizophrenia (Karlsgodt et
al., 2008; Lim et al., 1999; McGlashan & Hoffman, 2000; Meyer-Lindenberg et al., 2001;
Weinberger et al., 1994). Consistent with this view, CHR individuals who convert to
psychosis display an increased rate of prefrontal gray matter contraction relative to non-
converting high-risk individuals (Pantelis et al., 2003; Sun et al., 2009), and CHR patients
overall show an absence of age-related increases in white matter integrity compared with
controls (Karlsgodt et al., 2009). While little work has focused on emotion processing, prior
studies have demonstrated neural abnormalities associated with working memory and verbal
fluency among CHR patients (Broome et al., 2009; Fusar-Poli et al., 2010; Smieskova et al.,
2011).
The physiological consequences of structural brain maturation during adolescence involve
fine-tuning of functional circuitry. Typically, a shift from short-range to long-range
functional connectivity leads to separable networks and increased efficiency, with
socioemotional networks achieving functional maturation later than sensory-motor networks
(Fair et al., 2007; Kelly et al., 2009). Protracted development of networks subserving
emotion regulation may derive from differential maturational timecourses of subcortical and
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prefrontal regions, increasing risk for emotion dysregulation during adolescence (Galvan et
al., 2006). This circuitry is likely to be especially vulnerable among individuals with deficits
in prefrontal structural integrity – i.e., CHR individuals who progress to full psychosis (e.g.,
Pantelis et al., 2003).
The present cross-sectional study investigated whether CHR patients display altered age-
related patterns of amygdala and prefrontal function. Brain activation was evaluated with
functional magnetic resonance imaging (fMRI) during an emotional processing task
(Lieberman et al., 2007). Prior work using this task has demonstrated robust amygdala and
prefrontal activation, as well as evidence for the role of ventrolateral prefrontal cortex
(vlPFC) in modulating amygdala reactivity during emotion labeling, a condition
representing an incidental form of emotion regulation (Hariri et al., 2000; Lieberman et al.,
2007).
Since the prefrontal-subcortical regulatory relationship becomes stronger (Casey et al.,
2008) and activation in task-relevant regions increases across typical development (Durston
et al., 2006), we expected increased vlPFC and decreased age-related amygdala activation
among controls. We hypothesized that CHR patients would demonstrate decreased
amygdala-prefrontal functional connectivity, as well as altered trajectories of amygdala and
prefrontal activation, relative to controls. This pattern of findings would be consistent with a
failure of prefrontal cortex to regulate amygdala reactivity, resulting in increased amygdala
activity with increasing age.
2. Materials and Methods
2.1 Participants
Participants were 20 CHR adolescents and 14 age- and gender-matched healthy controls
between 15 and 23 years old. The protocol was approved by Institutional Review Boards at
the sites participating in the North American Prodrome Longitudinal Study (NAPLS), from
which participants were drawn (Emory University, Harvard University, University of
Calgary, University of California Los Angeles (UCLA), University of California San Diego,
University of North Carolina (UNC), Yale University, Zucker Hillside Hospital), and
participants provided informed consent or assent (parental informed consent for minors).
The data in this report are from the initial qualifying phase of the fMRI component of the
NAPLS consortium, in which four sites contributed scan data. This phase was used to
collect preliminary data to evaluate the applicability of the present emotional processing
paradigm in a sample of CHR youth. Based on results of this preliminary investigation, the
paradigm has been implemented in the full NAPLS study, for which data collection is
ongoing through 2013.
2.2 Clinical Measures
Participants were screened using the Structured Interview for Prodromal Syndromes (SIPS;
McGlashan et al., 2001) for the presence of a prodromal syndrome: attenuated subthreshold
psychotic symptoms, brief intermittent psychotic symptoms, substantial functional decline
combined with genetic risk for psychosis, or schizotypal personality disorder in individuals
<18 years old. CHR participants were excluded if they met DSM-IV criteria for an Axis I
schizophrenia-spectrum disorder. Control participants were excluded if they met DSM-IV
criteria for a psychiatric disorder, had a first-degree relative with a current or past psychotic
disorder, or met prodromal criteria. General exclusions included substance dependence (past
6 months), neurological disorder, or Full Scale IQ <70. Overall functioning was measured
using the Global Assessment of Functioning (GAF) scale.
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2.3 fMRI Task Paradigm
The experimental paradigm consisted of an emotional faces task (Hariri et al., 2000;
Lieberman et al., 2007) (Figure 1). Participants viewed target faces or shapes while
performing one of five tasks in each block of 10 trials (each trial was 5 seconds; i.e., 50-
second blocks in randomized order). Each condition type occurred once in each of two
functional runs. Emotion labeling involved choosing which of two labels (e.g., “angry,”
“happy,” “scared,” “surprised”) described a target face. Gender labeling involved selecting
the gender-appropriate name for a target face. Emotion matching involved choosing which
of two faces displayed the same emotion as a target face. Gender matching involved
selecting which of two faces was the same gender as a target face. Shape matching involved
selecting which of two shapes was the same as a target shape. Facial stimuli were chosen
from a standardized set (Tottenham et al., 2009). Additional details appear elsewhere
(Lieberman et al., 2007). Emotion labeling is considered to represent a form of incidental
emotion regulation (Lieberman et al., 2007) and has been associated with decreases in
negative emotion (Lieberman, Inagaki, Tabibnia, & Crockett, 2011) and reduced
physiological responsivity (Tabibnia, Lieberman, & Craske, 2008). For this reason, we
focused on emotion labeling in the present study, with appropriate contrasts (e.g., emotion
labeling versus gender labeling, emotion labeling versus emotion matching) selected based
on prior work (Lieberman et al., 2007).
2.4 Functional Imaging Parameters
Scanning was performed on Siemens Trio 3.0 Tesla (3T) scanners (UCLA, n=17; Yale
University, n=2), a Siemens Allegra 3T scanner (UNC, n=14), and a GE 3T scanner (Zucker
Hillside Hospital, n=1). A standard radiofrequency head coil was employed. Anatomical
reference scans were acquired to configure slice alignment. A T2-weighted image (0.9-mm
in-plane resolution) was acquired using a set of high-resolution echo planar (EPI) localizers
(Siemens: TR/TE 6310/67ms, 30 4-mm slices with 1-mm gap, 220-mm FOV; GE: TR/TE
6000/120ms, 30 4-mm slices with 1-mm gap, 220-mm FOV). Functional scans matched the
AC-PC aligned T2 image and utilized an EPI sequence (TR/TE 2500/30ms, 77 degree flip
angle, 30 4-mm slices). Each functional run consisted of 129 volumes.
2.5 Image Processing
Functional image analysis was performed using FSL (FMRIB’s Software Library v. 4.0;
Smith et al., 2004). Motion in EPI data was corrected using a six-parameter, rigid-body 3D
co-registration (FLIRT), which registered each BOLD image to the middle data point in the
timeseries. Data were registered for each participant (EPI to participant’s T2-weighted
structural image, then T2 to standard space brain) (Jenkinson & Smith, 2001; Jenkinson et
al., 2002). Data were spatially smoothed with a 5-mm (FWHM) Gaussian kernel and filtered
with a non-linear high-pass filter (120s cut-off). Individual participant analyses employed
FEAT (FMRI Expert Analysis Tool).
Timeseries statistical analysis on each participant was carried out using FILM (FMRIB’s
Improved Linear Model) with local autocorrelation correction. A univariate general linear
model (GLM) was applied on a voxel-by-voxel basis such that each voxel’s timeseries was
individually fitted to the resulting model, with local autocorrelation correction applied
within tissue type to improve temporal smoothness estimation (Smith et al., 2004; Woolrich
et al., 2001). Each voxel’s goodness-of-fit to the model was estimated; resulting parameter
estimates indicated the degree to which signal change could be explained by each model.
Each condition was modeled separately, with each correct trial modeled in its entirety in a
block design fashion. Motion parameters were entered as covariates; participants with
motion >3mm were excluded.
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Resulting contrast images were entered into second-level analyses (fixed effects model) to
combine functional runs for each participant and to allow for inferences at the group level.
Group analysis was carried out using FLAME (FMRIB’s Local Analysis of Mixed Effects)
(Behrens et al., 2003; Smith et al., 2004) with each participant’s data, including parameter
and variance estimates for each contrast from the lower-level analysis. To correct for
multiple comparisons, resulting Z-statistic images were thresholded using clusters
determined by Z>2.3 and a corrected cluster significance threshold of p=0.05 (Forman et al.,
1995; Friston et al., 1994; Worsley et al., 1992). Cluster p-values were determined using
spatial smoothness estimation in FEAT.
2.6 Regions of Interest
Regions of interest (ROI) were selected based on prior work (Lieberman et al., 2007). An
anatomically-defined left amygdala mask was defined using the Harvard-Oxford Structural
Atlas (Kennedy et al., 1998; Makris et al., 1999). Voxels with atlas-derived values
corresponding to a ≥25% probability of belonging to the left amygdala were included. For
the vlPFC ROI, a spherical (diameter=10mm) mask was created with center at coordinates
for peak vlPFC activation (56, 22, 8) during emotion labeling versus gender labeling among
controls in prior work (Lieberman et al., 2007) (Figure 2). FSL’s Featquery was used to
warp ROIs back into each participant’s space by applying the inverse of the transformation
matrix used during the initial registration. The motion-corrected, smoothed, and filtered data
were probed for mean percent signal change during emotion labeling versus emotion
matching in the left amygdala and during emotion labeling versus gender labeling in the
right vlPFC. These contrasts for the amygdala and vlPFC were selected based on their use in
research with the same task in healthy controls (Hariri et al., 2000; Lieberman et al., 2007).
2.7 Age-Related Analyses of Functional Activation
A GLM was constructed to model age for each group while covarying for sex. This analysis
allowed for examination of an interaction by producing statistical maps of regions for which
activation increased for patients while decreasing with age for controls, or vice versa (see
Supplemental Methods and Results). Following group-level analyses in FSL, an ROI
approach was used to examine age-related amygdala and vlPFC activation in each group.
For each ROI, a regression analysis was conducted in SPSS 18.0 predicting percent signal
change based on age, group, a group × age interaction, and sex. The interaction term was
used to examine whether age trajectories of functional activation differed between groups.
To avoid effects of outliers, participants with a studentized residual or studentized deleted
residual <−3 or >3 were removed, resulting in exclusion of one CHR participant.
We also tested whether site significantly predicted activation results in ROI analyses of the
amygdala and vlPFC or functional connectivity results in the psychophysiological
interaction (PPI) analysis conducted across all voxels in the brain. No differences were
found between sites, thus site was removed from models to preserve degrees of freedom.
Initial between-group analyses were conducted to compare whole-brain activation of
patients and controls, regardless of age. In general, patients showed a pattern of
hypoactivation across relevant task contrasts (see Supplemental Methods and Results).
However, the group effects were not particularly robust, and between-group ROI analyses of
the amygdala and vlPFC were not significant, because analyses of developmental
trajectories revealed that the direction of patient and control differences varied across the
age continuum.
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2.8 Psychophysiological Interaction Analysis
A PPI analysis (Friston et al., 1997) was conducted to examine whether task-dependent
functional connectivity between the amygdala and prefrontal regions differed between
groups. That is, the PPI analysis tested whether CHR patients and controls differed on the
extent to which the amygdala covaried with other brain regions more during emotion
labeling than during emotion matching. Emotion labeling versus emotion matching was
chosen as the task contrast of interest because prior studies in healthy individuals have
demonstrated stronger amygdala-prefrontal coupling during emotion labeling than emotion
matching (Lieberman et al., 2007).
The GLM analysis was carried out in FSL with regressors for task, seed region timeseries,
and the interaction of task and timeseries. The psychological (task condition) regressor
modeled whether a given trial consisted of emotion labeling or emotion matching. The
physiological (seed region timeseries) regressor comprised the timeseries for the left
amygdala. A third regressor modeled the interaction of the psychological regressor and the
physiological regressor, such that it identified regions that covaried in a task-dependent
manner with the amygdala (i.e., regions that significantly correlated more with the amygdala
during emotion labeling than during emotion matching).
As in the prior analyses of functional activation, a first level analysis was conducted for each
individual participant to identify regions that significantly covaried with the amygdala in a
task-dependent manner for each run. A second level analysis combined results from the first
and second run for each participant. Finally, a group level analysis identified differences
between CHR patients and controls in terms of regions that significantly covaried with the
amygdala more during emotion labeling than during emotion matching. Group analysis was
carried out using FLAME (Behrens et al., 2003; Smith et al., 2004), and resulting Z-statistic
images were thresholded using clusters determined by Z>2.3 and a corrected cluster
significance threshold of p=0.05 to correct for multiple comparisons (Forman et al., 1995;
Friston et al., 1994; Worsley et al., 1992).
2.9 Demographic and Behavioral Data Analysis
Independent sample t-tests or chi-square tests were used to compare age, gender, GAF score,
and task performance (accuracy, reaction time (RT)) between patients and controls, as
appropriate. Paired sample t-tests compared mean accuracy and mean RT between




The CHR and control groups did not differ on age (p=.913) or sex (X2 = .68, p=.410). As
shown in Table 1, the majority of CHR patients (17/20) met criteria for Attenuated Positive
Symptoms. Patients exhibited significantly lower overall functioning (GAF) relative to
controls (p<.001). Two of the 20 CHR participants had converted to psychosis (10%) at the
time of this analysis; since most of the subjects had not yet been followed for more than 6
months, several more cases would be expected to convert over the next few years. Given the
number of conversions to date, it was not possible to conduct analyses comparing activation
or functional connectivity for converting versus non-converting CHR participants.
3.2 Behavioral Task Performance
Participants performed the task with a mean accuracy of 92.8% across conditions (Table 2).
Patients and controls did not significantly differ on accuracy overall or on any condition.
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Overall, participants displayed greater accuracy for gender labeling versus emotion
matching (p=.004) and emotion labeling (p=.025) and for shape matching versus emotion
matching (p=.036). Patients and controls did not differ in RT overall or on any condition
(Table 3). Overall, participants responded faster during shape matching than any other
condition (p<.050). Mean RT was faster for gender matching than gender labeling, emotion
matching, and emotion labeling (p<.001), for gender labeling versus emotion labeling or
emotion matching (p<.001), and for emotion labeling versus emotion matching (p<.001).
Age and site did not significantly relate to RT or accuracy.
3.3 Age-Related vlPFC Functional Activation
Regression analysis revealed a significant group × age interaction in the right vlPFC
(F(4,29) = 5.43, p = .027), such that age-related trajectories of functional activation during
emotion labeling versus gender labeling differed between CHR patients and controls (Figure
3). Controls showed increasing vlPFC activation with increasing age, whereas CHR patients
showed decreasing vlPFC activation with increasing age. There were no significant main
effects of group, age, or sex (Table 4).
3.4 Age-Related Amygdala Functional Activation
There was a significant group × age interaction for functional activation during emotion
labeling versus emotion matching in the left amygdala (F(4,28) = 4.84, p = .037; Figure 4).
This analysis demonstrated an opposite pattern of age-related trajectories for the amygdala
compared with vlPFC. Controls showed decreasing amygdala activation with increasing age,
whereas CHR patients showed increasing amygdala activation with increasing age. There
were no significant main effects of group, age, or sex (Table 5).
3.5 Functional Connectivity between Amygdala and Prefrontal Regions
Task-dependent functional connectivity differed between CHR patients and controls, such
that patients exhibited weaker inverse amygdala-prefrontal covariation relative to controls
for emotion labeling relative to emotion matching. In a whole-brain analysis, this effect was
observed in the left orbitofrontal gyrus and left inferior frontal gyrus (Z=3.82, p=.027,
corrected) (Figure 5). The peak of covariation with the amygdala was at coordinates −50,
32, −10. When statistical maps of covariation with the amygdala were examined for each
group separately, no regions significantly covaried with the amygdala in the CHR group.
3.6 Medication Use
In order to examine whether medication use influenced findings, we examined the effects of
antipsychotic and antidepressant use in separate analyses. Functional activation and
connectivity did not significantly relate to use of either class of drug, and all findings
remained significant over and above medication status (see Supplemental Methods and
Results).
4. Discussion
The present study examined age-related trajectories of neural circuitry subserving emotion
regulation in adolescents at CHR for psychosis and typically developing adolescents. The
findings indicated that CHR adolescents display altered age-related differences in functional
activation in amygdala and prefrontal regions relative to controls, suggesting that
abnormalities in emotion-related neural circuitry may exist prior to illness onset and may
emerge with development over time. In addition, CHR adolescents exhibited decreased
amygdala-prefrontal functional connectivity, consistent with findings of disconnectivity in
schizophrenia. To our knowledge, this is the first study to examine functional connectivity
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and trajectories of functional activation in CHR subjects in regions important to emotion
processing. These findings provide novel insight into disrupted amygdala-prefrontal
interactions and the possible developmental course of these abnormalities in at-risk patients.
Age-related differences in functional activation observed among controls were consistent
with expected development. We selected a circumscribed prefrontal region shown to be
important for emotion labeling (Lieberman et al., 2007); the pattern of increasing vlPFC
activation with age is consistent with prior evidence of a generally increased magnitude of
activation in task-relevant regions with age (Durston et al., 2006; Pfeifer et al., 2011). By
contrast, there was a pattern of reduced amygdala activation with age; this effect may derive
from enhanced regulatory control and increasing strength of functional circuitry, as
networks subserving emotion regulation continue to develop throughout adolescence (Kelly
et al., 2009). Though research has demonstrated a general developmental shift from diffuse
to focal activation (e.g., Durston et al., 2006), there might also be differences in global
versus task-specific activation changes, as well as different age-related activation patterns
depending on task domain (e.g., emotional versus executive function).
In contrast to age-related patterns among controls, CHR adolescents exhibited decreased
vlPFC activation and increased amygdala activation with age, consistent with emotion
dysregulation, and weaker inverse amygdala-vlPFC functional connectivity, supporting the
relevance of disconnectivity to psychosis onset. Disruptions in structural and functional
connectivity may prevent adequate regulation of amygdala activity. A similar pattern was
seen in a study of adults with schizophrenia; patients displayed greater amygdala reactivity,
as well as decreased amygdala-prefrontal functional connectivity (Fakra et al., 2008).
Understanding the nature of physiological systems subserving emotion processing has
important implications. Emotion-related deficits in schizophrenia interfere with
socioemotional functioning, social cognition, and functional outcomes (Hooker & Park,
2002; Kee et al., 2003; Pinkham et al., 2003). As such, continued emotional disturbances
may contribute to ongoing functional impairment in schizophrenia even after positive
symptoms are treated. The present findings suggest that CHR patients exhibit alteration in
an incidental form of emotion regulation (i.e., emotion labeling). Though individuals are not
asked to try to regulate their emotions during emotion labeling, prior research has
demonstrated that this process is associated with common effects of emotion regulation,
including reductions in self-reported distress, decreased physiological reactivity, increased
vlPFC activation, decreased amygdala activity, and negatively correlated prefrontal and
amygdala responses (Hariri, Bookheimer, & Mazziotta, 2000; Lieberman et al., 2007;
Tabibnia, Lieberman, & Craske, 2008; Payer, Lieberman, & London, 2011; Lieberman,
Inagaki, Tabibnia, & Crockett, 2011). While future research is necessary to elucidate the
functional implications of this implicit psychological process, prior work on emotion
labeling demonstrating its effects of reducing subjective reports of negative emotion
(Lieberman, Inagaki, Tabibnia, & Crockett, 2011) and reducing physiological reactivity
(Tabibnia, Lieberman, & Craske, 2008) suggests that alterations in this process and in
amygdala-vlPFC circuitry may have important consequences for patients at risk for
psychosis.
The psychosis prodrome allows for a unique examination of emotion-related neural circuitry
prior to overt illness, while minimizing common confounds (e.g., long-term antipsychotic
treatment). Given the heterogeneous outcomes of CHR participants (Cannon et al., 2008),
future work would benefit from comparing converters and non-converters. This study is
limited by several factors to be addressed in future research. First, the sample size is
relatively modest, as the data were collected as part of an initial phase of a larger study.
Results indicate that the emotional processing paradigm is appropriate for use in the CHR
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population and support the decision to incorporate this paradigm in ongoing NAPLS data
collection. Follow-up research with larger samples will be critical for elucidating
developmental changes in amygdala-prefrontal interactions. It is important to note, however,
that in general small sample size is problematic due to low power to detect statistical effects;
in this case, power was clearly sufficient to detect numerous effects of interest. Second, our
data are cross-sectional; thus, the present results do not represent within-subject
developmental trajectories, and it will be important to examine whether these results
replicate in longitudinal follow-up data. Third, a subset of CHR participants has been
exposed to medication; however, there was no evidence that medication use influenced the
current findings, as the measures of functional activation and connectivity did not relate to
medication use. Fourth, though we did not detect between-site differences, it will be
important to address the issue of multi-site data collection in larger samples with increased
power to test for site-specific effects. We re-analyzed the present data excluding participants
from Yale University and Zucker Hillside Hospital and observed the same results (see
Supplemental Methods and Results). Finally, the CHR group represents a clinically
heterogeneous sample, and only a subset of the CHR sample is likely to develop psychosis.
Thus, future work comparing converters with non-converters will greatly enhance
knowledge of the relationship between amygdala-prefrontal circuitry and later psychosis.
We did not find group- or age-related performance differences, suggesting that observed
differences in brain activation were not secondary to behavioral differences. Although prior
research has demonstrated altered performance among schizophrenia patients (Fakra et al.,
2008), CHR individuals may not yet exhibit performance differences on this task. Changes
in brain activation may precede or predict behavioral deterioration. The lack of performance
differences may also relate to the sample’s heterogeneous nature (e.g., not all CHR
participants will develop psychosis).
Our findings are consistent with the hypothesis that patients at CHR for psychosis display
altered trajectories of neurodevelopment in the amygdala and prefrontal cortex, as well as
decreased functional connectivity among regions subserving emotion regulation, relative to
controls. Given the debilitating socioemotional deficits associated with schizophrenia, the
present findings provide critical insight into emotion-related abnormalities in neural
circuitry that are present prior to overt psychosis. Moreover, knowledge about early
disruptions in amygdala-prefrontal interactions may enhance prediction of later
socioemotional functioning and conversion to psychosis.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Task Design
The emotional faces fMRI task consisted of Emotion Labeling and Emotion Matching, as
well as non-emotional control conditions of Gender Labeling, Gender Matching, and Shape
Matching (adapted from Lieberman et al., 2007).
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Figure 2. Regions of Interest
Regions of interest for the left amygdala (left) and right vlPFC (right) are shown. For the left
amygdala, an anatomical ROI was used based on the probabilistic Harvard-Oxford
Structural Atlas. The right vlPFC ROI mask was created using a spherical ROI centered at
56, 22, 8, a peak of activation for emotion labeling versus gender labeling in a study of
healthy controls (Lieberman et al., 2007).
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Figure 3. vlPFC Trajectories
Analysis of the right vlPFC revealed a significant interaction (F(4,29) = 5.43, p = .027)
between age-related trajectories of functional activation during emotion labeling versus
gender labeling for CHR patients and controls, such that controls showed increasing vlPFC
activation whereas CHR patients showed decreasing vlPFC activation across development.
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Figure 4. Amygdala Trajectories
Regression analysis demonstrated a significant interaction (F(4,28) = 4.84, p = .037)
between age-related trajectories of left amygdala activation during emotion labeling versus
emotion matching for CHR patients and controls, such that controls exhibited decreasing
amygdala activation whereas CHR patients showed increasing amygdala activation with
increasing age.
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Figure 5. Amygdala-Prefrontal Functional Connectivity
CHR patients demonstrated weaker inverse task-dependent functional connectivity between
the amygdala and prefrontal regions consisting of left orbitofrontal cortex and left inferior
frontal gyrus, compared with controls (Z = 3.82, p = .027, corrected).
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Table 1





Age (years, SD) 18.7 (2.5) 18.8 (2.4)
Sex (male/female) 5/9 10/10
Primary prodromal criteria (n)
Attenuated Positive Symptoms (APS)* n/a 17
Brief Intermittent Psychotic Symptoms (BIPS) n/a 1
Youth & Schizotypy (YS) n/a 2
GAF score (mean, SD) 88.8 (5.4) 50.3 (9.4)
Race/ethnicity (n)
White (European) 5 10
Hispanic 3 3
Black 1 2
Southeast Asian 1 2
Interracial 3 1
First Nations (North American Indian, Metis, Inuit) 0 1
Native Hawaiian or Pacific Islander 0 1
West/Central Asian or Middle Eastern 1 0
Medication status (n)
Current atypical antipsychotic 0 5
Current antidepressant 0 6
Current psychostimulant 0 2
Current other (Abilify, Cogentin, Klonopin) 0 3
No current medication 14 12
One current medication 0 2
Two current medications 0 3
Three current medications 0 2
Four current medications 0 1
*
Two CHR participants with Attenuated Positive Symptoms (APS) also met criteria for Youth & Schizotypy (YS), and one other CHR participant
with APS also met criteria for Genetic Risk & Deterioration (GRD).
Demographic information and clinical characteristics are displayed for the sample. There was no significant difference in the age or gender
distribution of the groups. For the CHR patient group, the majority of participants met Attenuated Positive Symptom (APS) criteria. Brief
Intermittent Psychotic Symptom (BIPS), Genetic Risk and Deterioration (GRD), and Youth and Schizotypy (YS) were also considered inclusion
criteria for the prodromal group. CHR patients displayed significantly poorer functioning compared with controls, as measured by GAF score (p<.
001).
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Table 2
Mean Accuracy (%) by Group
Patients Controls t p
Total 92.6 93.2 −0.270 0.789
Shape Match 92.5 95.4 −0.877 0.387
Emotion Match 90.8 88.9 0.442 0.661
Gender Match 94.5 90.7 0.853 0.400
Gender Label 93.5 97.5 −1.534 0.135
Emotion Label 92.0 93.6 −0.697 0.491
Mean accuracy scores (in percentage correct) are displayed for patients and controls. There were no significant differences in accuracy of
performance between groups.
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Table 3
Mean Reaction Time (msec) by Group
Patients Controls t p
Total 1522 1537 −0.154 0.878
Shape Match 1196 1244 −0.518 0.608
Emotion Match 1936 1929 0.062 0.951
Gender Match 1294 1354 −0.562 0.578
Gender Label 1459 1442 0.172 0.865
Emotion Label 1747 1715 0.245 0.808
Mean reaction times (in msec) are shown for patients and controls. There were no significant differences in reaction time between groups.



























































































































































































































































































































































































































































































































































































































Schizophr Res. Author manuscript; available in PMC 2013 January 1.
